EDGAR Filing Documents for 0001193125-23-257885

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001193125-23-257885

Filing Date

2023-10-18

Accepted

2023-10-17 19:27:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D/A	d547778dsc13da.htm	SC 13D/A	39998
2	EX-99.4	d547778dex994.htm	EX-99.4	31619
	Complete submission text file	0001193125-23-257885.txt		72907

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807

Business Address (908) 947-3120

Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 231330648
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TARSADIA INVESTMENTS 520 NEWPORT CENTER DRIVE, 21ST FLOOR NEWPORT BEACH CA 92660

Business Address

Patel Tushar Bhikhubhai (Filed by) CIK: 0001745375 (see all company filings)

Type: SC 13D/A